Regulations for the licensing, production and export of Medicinal Cannabis in Jersey
Launch date: 13/04/2021
Review status: Review started
What is the review about?
An in-depth review examining the regulations for the licence application, production, and export of medicinal cannabis in Jersey.
As well as comparing the regulations for licence application with other jurisdictions, the Panel will consider its impact on Jersey's international reputation and assess how economically beneficial this new sector will be for the Island. The review will also assess how robust the application process is to ensure thorough due diligence is undertaken on applicants. To inform its review, the Panel will engage with relevant Ministers and industry representatives. Following this, recommendations will be presented to the Minister for Economic Development, Tourism, Sport, and Culture as well as the States Assembly in a mid-June report.
The Panel has launched its Review
Terms of reference
1. To examine and benchmark the Regulations establishing the terms of licensing for the cultivation, import and export of medicinal cannabis and the comparison with other relevant jurisdictions.
2. To examine the merits to the Island of requiring applicants to obtain EU/Good Manufacturing Practice (GMP) certification.
3. To evaluate the projected economic benefit to the Island of this sector, including identifying any inherent costs to the taxpayer of associated regulation and administration.
4. To identify and evaluate the full scope of the tax regime associated with the sector.
5. To examine any potential impact, positive or negative, on the international reputation of the Island in establishing an industry based on the cultivation, import and export of medicinal cannabis.